Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adaptive survival trials

W F Rosenberger1, P Seshaiyer

  • 1Department of Mathematics and Statistics, University of Maryland, Baltimore County 21250, USA.

Journal of Biopharmaceutical Statistics
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational and Mathematical Methods to Estimate the Basic Reproduction Number and Final Size for Single-Stage and Multistage Progression Disease Models for Zika with Preventative Measures.

Computational and mathematical methods in medicine·2017
Same author

A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.

Methods of information in medicine·2015
Same author

Association of fasting glucose with subclinical cerebrovascular disease in older adults without Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2013
Same author

Covariate-adjusted response-adaptive designs for binary response.

Journal of biopharmaceutical statistics·2002
Same author

Optimal adaptive designs for binary response trials.

Biometrics·2001
Same author

On the potentially protective role of contact constraints on saccular aneurysms.

Journal of biomechanics·2001
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces adaptive survival trials that ethically adjust treatment randomization based on real-time patient data. This method maintains statistical power while improving patient outcomes in clinical research.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Medical Research

Background:

  • Adaptive clinical trials offer flexibility in study design.
  • Ethical considerations are paramount in patient-centered research.
  • Real-time data analysis can inform trial adaptations.

Purpose of the Study:

  • To design an adaptive survival trial.
  • To ethically skew randomization probabilities based on accumulating data.
  • To evaluate the performance of this adaptive design.

Main Methods:

  • Developed a formula to map the logrank statistic to randomization probabilities.
  • Implemented a biased coin randomization procedure.
  • Utilized simulation studies to assess the design's efficacy.

Related Experiment Videos

Main Results:

  • The adaptive allocation scheme demonstrated effective performance.
  • The design provides a more ethical approach for survival trials.
  • Statistical power was not negatively impacted by unequal allocation.
  • The standard test statistic maintained its distribution under the proposed scheme.

Conclusions:

  • Adaptive survival trials can ethically and effectively utilize accumulating patient data.
  • This design offers a viable alternative to traditional fixed randomization methods.
  • Further research can explore applications in various clinical settings.